Alex Haowen Lin

Mr. Alex Haowen Lin

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ALAlex Haowen Lin
Alex Haowen Lin
HCHoi Wai Chan
Hoi Wai Chan
KCKa Man Cheung
Ka Man Cheung
ACAmy M. K. Chu
Amy M. K. Chu
SHSharon C. L. Ho
Sharon C. L. Ho
JLJoshua Jing Xi Li
Joshua Jing Xi Li
Prostate-specific antigen (PSA) is a well-established marker for prostate cancer screening, but current ≥4 ng/mL cutoff suffers from low specificity. This study aims to demonstrate the use of a long short-term memory (LSTM) network for accurate prediction of prostate cancer risk and next sequential PSA value. Hong Kong-wide PSA test data over a 25-year period, including PSA values, time difference between PSA tests, and PSA velocity change, were retrieved for model training with variable PSA cutoffs and sequence length. A total of 1,158,915 PSA tests from 499,342 patients (including 18,629 patients with prostate cancer) were included. Models predicting the next PSA level performed well (accuracy 0.724–0.910, AUROC 0.751–0.892). For a ≥4 ng/mL cutoff, the best model was at sequence length of 4 (AUROC 0.864). Temporal prediction of PSA performance was lower (accuracy 0.739–0.811, AUROC 0.740–0.849). Prostate cancer prediction performed excellent (AUROC 0.888–0.973), the sensitivity (0.734), and specificity (0.962) were high even at the shortest sequence length and a ≥4 ng/mL cutoff (4). Utilizing PSA levels only without additional markers or clinical data, LSTM-based models accurately predicted the next PSA level with modest temporal predictions while significantly improving the specificity of prostate cancer risk prediction, demonstrating their clinical utility.